Andere talen NP Inc.

Aandelen

A291230

KR7291230001

slotkoers Korea S.E. Andere beurzen 00:00:00 02-07-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
2.085 ^KRW	-5,44%		-6,71%	-35,85%

27/03	Algernon Pharmaceuticals zegt dat overname van het Ifenprodil-programma door Amerikaans bedrijf is afgerond	MT
07/03	17% gedaald, BioVaxys Technology Corp. Geeft tweewekelijkse MCTO-statusupdate	MT

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

Gratis inschrijven

Ultra Lithium Provides Bi-Weekly Default Status Report	03/04
Shanaya’s Subsidiary Enters MOU with Ngee Ann Polytechnic; Shares Surge 10%	29/03
Algernon Pharmaceuticals Says Acquisition of Ifenprodil Program Completed by US Company	27/03
Down 17%, BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update	07/03
MCF Energy Acquired "Accretive" Czech Gas Projects With "Immediate Production And Growth Potential"	26/02
MCF Energy Acquires Accretive Czech Gas Projects with Immediate Production and Growth Potential	26/02
Vizsla Silver Up 0.75% In US Premarket After Reporting Additional High Grade Intercepts at La Luisa	13/02
Algernon Pharmaceuticals Receives Notice of Intention to Grant from Chinese Patent Office for Repirinast to Treat CKD	31/01
Algernon Pharmaceuticals Receives Notice of Intention to Grant from Chinese Patent Office for Repirinast	30/11
Algernon Pharma in LOI For Acquisition of its Chronic Cough Research Program For US$2 Million and 20% Equity Stake	22/11
ETF de la semana: Un pie en la renovación de las infraestructuras estadounidenses	03/11
Npl : Unirec rilancia cartolarizzazione sociale (MF)	20-10-23
ETF de la semana: Puede que el gas no haya dicho su última palabra	19-10-23
ETF de la semana: Diversificar con bonos	11-10-23
Aehr Test Systems Receives Initial Order From Unnamed New Customer for Wafer Level Test, Burn-in Systems	18-09-23
Algernon Pharmaceuticals Announces Grant of U.S. Patent for Repirinast in NAFLD and NASH	06-09-23
Novelplus Technology Trims Loss in H1	15-08-23
Napo Pharmaceuticals Submits Funding Application to BARDA for NP-300 Development	09-08-23
Moody's Withdraws Ratings on Austria's Addiko Bank	09-08-23
Algernon Pharmaceuticals Engage Maxim Group to Explore Spin-Off of Ifenprodil Phase 2 Chronic Cough Drug Development Program	27-06-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen NP Inc.

Aandelen

A291230

KR7291230001

Andere talen

Filters